These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24378765

  • 1. Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens.
    Bushmakin AG, Abraham L, Pinkerton JV, Cappelleri JC, Mirkin S.
    Menopause; 2014 Aug; 21(8):815-22. PubMed ID: 24378765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
    Pinkerton JV, Utian WH, Constantine GD, Olivier S, Pickar JH.
    Menopause; 2009 Aug; 16(6):1116-24. PubMed ID: 19546826
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
    Pinkerton JV, Abraham L, Bushmakin AG, Cappelleri JC, Racketa J, Shi H, Chines AA, Mirkin S.
    J Womens Health (Larchmt); 2014 Jan; 23(1):18-28. PubMed ID: 24206058
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S, Komm BS.
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling.
    Pinkerton JV, Bushmakin AG, Racketa J, Cappelleri JC, Chines AA, Mirkin S.
    Menopause; 2014 Mar; 21(3):243-51. PubMed ID: 23899830
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.
    Palacios S, Arias L, Lavenberg J, Pan K, Mirkin S, Komm BS.
    Climacteric; 2016 Jun; 19(3):261-7. PubMed ID: 26940720
    [Abstract] [Full Text] [Related]

  • 17. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
    Mirkin S, Ryan KA, Chandran AB, Komm BS.
    Maturitas; 2014 Jan; 77(1):24-31. PubMed ID: 24246155
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials.
    Pinkerton JV, Pickar JH, Ryan KA, Yu CR, Mirkin S, Komm BS.
    Menopause; 2016 Jun; 23(6):611-20. PubMed ID: 27163519
    [Abstract] [Full Text] [Related]

  • 20. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.